These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 698972)

  • 21. Estrogen receptors, antibodies and hormone dependent cancer.
    DeSombre ER; Greene GL; King WJ; Jensen EV
    Prog Clin Biol Res; 1984; 142():1-21. PubMed ID: 6538684
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunohistochemical study of cytosolic estrogen receptor-bound protein in breast cancer. Correlation with a biochemical study. Apropos of 107 surgical specimens].
    Vildé F; Arkwright S
    Arch Anat Cytol Pathol; 1992; 40(1-2):7-11. PubMed ID: 1605702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of estradiol, progesterone, and prolactin receptors in nitrosomethylurea-induced mammary tumors and effect of antiestrogen treatment on the development and growth of these tumors.
    Turcot-Lemay L; Kelly PA
    Cancer Res; 1980 Sep; 40(9):3232-40. PubMed ID: 6253058
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of Ca2+ and salt on forms of estradiol cytoplasmic receptor in human neoplastic breast tissue.
    Schneider SL; Dao TL
    Cancer Res; 1977 Feb; 37(2):382-7. PubMed ID: 832263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidimensional chromatographic separation of estrogen receptors.
    Raubenheimer J; van der Walt LA
    Biomed Chromatogr; 1989 Nov; 3(6):255-61. PubMed ID: 2620146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Change in the level of steroid hormone receptors in the tumors of patients with breast cancer complicated by liver and bile duct diseases].
    Portnoĭ SM; Smirnova KD; Bassalyk LS; Murav'eva NI; Kuz'mina ZV
    Vopr Onkol; 1985; 31(1):55-9. PubMed ID: 3976195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macromolecular binding of dexamethasone as evidence for the presence of mineralocorticoid receptor in human breast cancer.
    Martin PM; Rolland PH; Raynaud JP
    Cancer Res; 1981 Mar; 41(3):1222-6. PubMed ID: 6780185
    [No Abstract]   [Full Text] [Related]  

  • 28. Study finds that hormone status may predict chemotherapy's effectiveness on breast cancer.
    McBride D
    ONS Connect; 2008 Jan; 23(1):25. PubMed ID: 18284079
    [No Abstract]   [Full Text] [Related]  

  • 29. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
    De Maeyer L; Van Limbergen E; De Nys K; Moerman P; Pochet N; Hendrickx W; Wildiers H; Paridaens R; Smeets A; Christiaens MR; Vergote I; Leunen K; Amant F; Neven P
    J Clin Oncol; 2008 Jan; 26(2):335-6; author reply 336-8. PubMed ID: 18182677
    [No Abstract]   [Full Text] [Related]  

  • 30. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
    Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ
    Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depletion of specific binding sites for estrogen receptor by Uncaria tomentosa.
    Salazar EL; Jayme V
    Proc West Pharmacol Soc; 1998; 41():123-4. PubMed ID: 9836266
    [No Abstract]   [Full Text] [Related]  

  • 32. Estrogen binding sites in the nucleus of normal and malignant human tissue: optimization of an exchange assay for the measurement of specific binding.
    Syne JS; Markaverich BM; Clark JH; Panko WB
    Cancer Res; 1982 Nov; 42(11):4443-8. PubMed ID: 7127286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of estrogen, progesterone and prolactin receptors in human breast cancer.
    Calandra RS; Charreau EH; Royer de Giaroli M; Baldi A
    Prog Clin Biol Res; 1984; 142():97-108. PubMed ID: 6709661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptor variants in human breast cancer.
    Murphy LC
    Mol Cell Endocrinol; 1990 Dec; 74(2):C83-6. PubMed ID: 2090511
    [No Abstract]   [Full Text] [Related]  

  • 35. Steroid receptor proteins in human meningiomas.
    Tilzer LL; Plapp FV; Evans JP; Stone D; Alward K
    Cancer; 1982 Feb; 49(4):633-6. PubMed ID: 7055777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective estrogen receptors in human mammary cancers: their significance in defining hormone dependence.
    Raam S; Robert N; Pappas CA; Tamura H
    J Natl Cancer Inst; 1988 Jul; 80(10):756-61. PubMed ID: 3290497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical basis for the selection of hormonal manipulation in the patient with breast carcinoma.
    Wittliff JL; Savlov ED
    Int J Radiat Oncol Biol Phys; 1978; 4(5-6):463-7. PubMed ID: 689947
    [No Abstract]   [Full Text] [Related]  

  • 38. Steroid receptors in early breast cancer: value in prognosis.
    Nicholson RI; Campbell FC; Blamey RW; Elston CW; George D; Griffiths K
    J Steroid Biochem; 1981 Dec; 15():193-9. PubMed ID: 7339245
    [No Abstract]   [Full Text] [Related]  

  • 39. Steroid hormone receptors and disease: breast cancer.
    McGuire WL
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):22-5. PubMed ID: 504231
    [No Abstract]   [Full Text] [Related]  

  • 40. Endocrine therapy of breast cancer. A background.
    Nordenskjöld B
    Acta Oncol; 1990; 29(3):367-9. PubMed ID: 2194538
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.